CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C09304 | BRD-K21786893 | BRD-K21786893 | -- | -- | -- | Details |
| C09305 | BRD-K21786986 | BRD-K21786986 | -- | -- | -- | Details |
| C09306 | BRD-K21787157 | BRD-K21787157 | -- | -- | -- | Details |
| C09307 | BRD-K21787371 | BRD-K21787371 | -- | -- | -- | Details |
| C09308 | BRD-K21788104 | BRD-K21788104 | -- | -- | -- | Details |
| C09309 | BRD-K21789048 | BRD-K21789048 | -- | -- | -- | Details |
| C09310 | BRD-K21796872 | BRD-K21796872 | -- | -- | -- | Details |
| C09311 | BRD-K21806131 | tegaserod | HTR2B; HTR4 | Serotonin receptor partial agonist | -- | Details |
| C09312 | BRD-K21815137 | cefotiam | -- | -- | -- | Details |
| C09313 | BRD-K21819164 | BRD-K21819164 | -- | -- | 6-(4-Heptyloxy-phenyl)-nicotinonitrile | Details |
| C09314 | BRD-K21822525 | BRD-K21822525 | -- | -- | -- | Details |
| C09315 | BRD-K21826560 | BRD-K21826560 | -- | -- | -- | Details |
| C09316 | BRD-K21827358 | BRD-K21827358 | -- | -- | -- | Details |
| C09317 | BRD-K21838437 | BRD-K21838437 | -- | -- | -- | Details |
| C09318 | BRD-K21841771 | BRD-K21841771 | -- | -- | -- | Details |
| C09319 | BRD-K21848683 | BRD-K21848683 | -- | -- | -- | Details |
| C09320 | BRD-K21852581 | BRD-K21852581 | -- | -- | -- | Details |
| C09321 | BRD-K21853356 | RG-14620 | EGFR | EGFR inhibitor | -- | Details |
| C09322 | BRD-K21855096 | BRD-K21855096 | -- | -- | -- | Details |
| C09323 | BRD-K21864149 | BRD-K21864149 | -- | -- | -- | Details |
| C09324 | BRD-K21866464 | BRD-K21866464 | -- | -- | -- | Details |
| C09325 | BRD-K21867462 | GSK-2816126 | -- | -- | -- | Details |
| C09326 | BRD-K21868159 | BRD-K21868159 | -- | -- | -- | Details |
| C09327 | BRD-K21879622 | BRD-K21879622 | -- | -- | -- | Details |
| C09328 | BRD-K21884483 | mizolastine | HRH1 | Histamine receptor antagonist | -- | Details |
| C09329 | BRD-K21893543 | BRD-K21893543 | -- | -- | -- | Details |
| C09330 | BRD-K21897482 | BRD-K21897482 | -- | -- | -- | Details |
| C09331 | BRD-K21898148 | BRD-K21898148 | -- | -- | -- | Details |
| C09332 | BRD-K21904592 | BRD-K21904592 | -- | -- | -- | Details |
| C09333 | BRD-K21906513 | UNC-669 | -- | -- | -- | Details |
| C09334 | BRD-K21908111 | azd1208 | -- | -- | -- | Details |
| C09335 | BRD-K21910317 | BRD-K21910317 | -- | -- | 2,4-dinitrophenol | Details |
| C09336 | BRD-K21913257 | BRD-K21913257 | -- | -- | -- | Details |
| C09337 | BRD-K21915746 | bromebric-acid | -- | -- | -- | Details |
| C09338 | BRD-K21918725 | BRD-K21918725 | -- | -- | -- | Details |
| C09339 | BRD-K21927299 | BRD-K21927299 | -- | -- | -- | Details |
| C09340 | BRD-K21933068 | BRD-K21933068 | -- | -- | -- | Details |
| C09341 | BRD-K21935128 | BRD-K21935128 | -- | -- | -- | Details |
| C09342 | BRD-K21936026 | BRD-K21936026 | -- | -- | -- | Details |
| C09343 | BRD-K21936341 | oxotremorine-sesquifumarate | CHRM2 | Cholinergic receptor agonist | -- | Details |
| C09344 | BRD-K21937603 | BRD-K21937603 | -- | -- | -- | Details |
| C09345 | BRD-K21953167 | BRD-K21953167 | -- | -- | -- | Details |
| C09346 | BRD-K21955335 | carbenoxolone | HSD11B1 | 11-beta-HSD1 inhibitor | -- | Details |
| C09347 | BRD-K21955645 | BRD-K21955645 | -- | -- | -- | Details |
| C09348 | BRD-K21955896 | BRD-K21955896 | -- | -- | -- | Details |
| C09349 | BRD-K21959862 | BRD-K21959862 | -- | -- | -- | Details |
| C09350 | BRD-K21962483 | BRD-K21962483 | -- | -- | -- | Details |
| C09351 | BRD-K21967348 | BRD-K21967348 | -- | -- | -- | Details |
| C09352 | BRD-K21968411 | BRD-K21968411 | -- | -- | -- | Details |
| C09353 | BRD-K21969044 | BRD-K21969044 | -- | -- | -- | Details |
| C09354 | BRD-K21971034 | OM-137 | -- | -- | -- | Details |
| C09355 | BRD-K21980308 | BRD-K21980308 | -- | -- | -- | Details |
| C09356 | BRD-K21982562 | BRD-K21982562 | -- | -- | -- | Details |
| C09357 | BRD-K21984629 | BRD-K21984629 | -- | -- | -- | Details |
| C09358 | BRD-K21986392 | BRD-K21986392 | -- | -- | -- | Details |
| C09359 | BRD-K21987633 | BRD-K21987633 | -- | -- | -- | Details |
| C09360 | BRD-K21990111 | BRD-K21990111 | -- | -- | -- | Details |
| C09361 | BRD-K21990363 | BRD-K21990363 | -- | -- | -- | Details |
| C09362 | BRD-K21991827 | BRD-K21991827 | -- | -- | -- | Details |
| C09363 | BRD-K21994180 | BRD-K21994180 | -- | -- | -- | Details |
| C09364 | BRD-K21996189 | BRD-K21996189 | -- | -- | -- | Details |
| C09365 | BRD-K21996934 | BRD-K21996934 | -- | -- | -- | Details |
| C09366 | BRD-K21997380 | BRD-K21997380 | -- | -- | -- | Details |
| C09367 | BRD-K22002184 | BRD-K22002184 | -- | -- | -- | Details |
| C09368 | BRD-K22002407 | BRD-K22002407 | -- | -- | -- | Details |
| C09369 | BRD-K22006123 | BRD-K22006123 | -- | -- | -- | Details |
| C09370 | BRD-K22009844 | phenprobamate | -- | -- | -- | Details |
| C09371 | BRD-K22010301 | JLK-6 | PSEN1 | Anti-amyloidogenic agent; Gamma secretase inhibitor | -- | Details |
| C09372 | BRD-K22010555 | BRD-K22010555 | -- | -- | -- | Details |
| C09373 | BRD-K22011492 | BRD-K22011492 | -- | -- | -- | Details |
| C09374 | BRD-K22013971 | BRD-K22013971 | -- | -- | -- | Details |
| C09375 | BRD-K22024824 | RG-4733 | -- | -- | -- | Details |
| C09376 | BRD-K22031190 | diflunisal | PTGS1; PTGS2 | Prostanoid receptor antagonist | -- | Details |
| C09377 | BRD-K22031742 | BRD-K22031742 | -- | -- | -- | Details |
| C09378 | BRD-K22033393 | BRD-K22033393 | -- | -- | -- | Details |
| C09379 | BRD-K22033912 | BRD-K22033912 | -- | -- | -- | Details |
| C09380 | BRD-K22039769 | BRD-K22039769 | -- | -- | -- | Details |
| C09381 | BRD-K22041611 | BRD-K22041611 | -- | -- | -- | Details |
| C09382 | BRD-K22045035 | BRD-K22045035 | -- | -- | -- | Details |
| C09383 | BRD-K22052171 | BRD-K22052171 | -- | -- | -- | Details |
| C09384 | BRD-K22062326 | BRD-K22062326 | -- | -- | -- | Details |
| C09385 | BRD-K22063616 | BRD-K22063616 | -- | -- | -- | Details |
| C09386 | BRD-K22065094 | BRD-K22065094 | -- | -- | -- | Details |
| C09387 | BRD-K22065327 | BRD-K22065327 | -- | -- | -- | Details |
| C09388 | BRD-K22069962 | BRD-K22069962 | -- | -- | -- | Details |
| C09389 | BRD-K22070096 | BRD-K22070096 | -- | -- | -- | Details |
| C09390 | BRD-K22071228 | BRD-K22071228 | -- | -- | -- | Details |
| C09391 | BRD-K22080587 | BRD-K22080587 | -- | -- | -- | Details |
| C09392 | BRD-K22081896 | BRD-K22081896 | -- | -- | -- | Details |
| C09393 | BRD-K22087390 | BRD-K22087390 | -- | -- | -- | Details |
| C09394 | BRD-K22093396 | BRD-K22093396 | -- | -- | -- | Details |
| C09395 | BRD-K22093970 | BRD-K22093970 | -- | -- | -- | Details |
| C09396 | BRD-K22096725 | ALW-II-49-7 | DDR1 | Ephrin inhibitor | -- | Details |
| C09397 | BRD-K22097595 | BRD-K22097595 | -- | -- | -- | Details |
| C09398 | BRD-K22097830 | OCO-1112 | -- | -- | -- | Details |
| C09399 | BRD-K22098045 | BRD-K22098045 | -- | -- | -- | Details |
| C09400 | BRD-K22101161 | BRD-K22101161 | -- | -- | -- | Details |
| C09401 | BRD-K22109269 | BRD-K22109269 | -- | -- | -- | Details |
| C09402 | BRD-K22123421 | BRD-K22123421 | -- | -- | -- | Details |
| C09403 | BRD-K22127577 | crenolanib | PDGFRA; PDGFRB | PDGFR inhibitor | -- | Details |